IL6 and metabolic syndrome: Of note, in relation to diet, IL-6 is also associated with the development of metabolic syndrome and cardiovascular disease in patients with RA, as demonstrated by the administration of IL-6 inhibitor, tocilizumab, leading to a subsequent increase in insulin sensitivity [63,64].